Statin use trajectories postbariatric surgery: a matched cohort analysis

Area of Science:

• Cardiology
• Endocrinology
• Bariatric Surgery

Background:

• Metabolic and bariatric surgery (MBS) is a highly effective long-term treatment for obesity.
• Obesity is a significant risk factor for cardiovascular diseases, often managed with statins.

Purpose of the Study:

• To compare statin utilization trajectories in patients before and after undergoing MBS.
• To evaluate the impact of MBS on the initiation and discontinuation of statin therapy.

Main Methods:

• A retrospective analysis of a U.S. employer-based claims database.
• Matching 16,359 adult patients who underwent MBS with 16,359 similar patients who did not.
• Examining statin use patterns in the two years following the index date.

Main Results:

• Among baseline statin users, 60.4% in the MBS group discontinued statins within two years, versus 35.4% in the non-MBS group.
• For statin-naive individuals, only 2.6% initiated statins post-MBS, compared to 9.6% in the non-MBS group.
• Statin use decreased significantly in the MBS cohort from 19.4% at baseline to 9.3% after two years.

Conclusions:

• Metabolic and bariatric surgery (MBS) leads to substantial statin discontinuation in patients previously using them.
• MBS significantly reduces the likelihood of initiating statin therapy in individuals not previously on medication.
• These findings highlight MBS as a crucial intervention for both treating and preventing dyslipidemia.